O10w2timqia3y9thhfts jm

Johnson Matthey

No Reviews Yet
No Completed Orders
London, GB

About Johnson Matthey

Founded: 1817 Type: Public Company

Johnson Matthey’s vision is for a world that’s cleaner and healthier, today and future generations. We are leaders in sustainable technologies and we apply our science to solve our customer’s most complex problems. We work with customers and partners across markets from pharmaceutical and medical to automotive, industrial and chemical production.


Our specialist technologies provide a substantial toolkit for diverse complex chemistries. They include an unmatched portfolio of homogeneous and heterogeneous catalyst technologies; chiral synthesis including chemocatalysis and biocatalysis platforms; controlled substances; highly potent APIs; expertise in drug-conjugate and linker technologies; solid state sciences; manufacturing-scale chromatography and purification sciences; as well as process analytical technologies.


Johnson Matthey has leading capabilities in developing optimal polymorphs, salt forms, crystal morphologies and controlled particles through our PHARMORPHIX® solid state sciences offering. The selection of a specific crystal, or amorphous, form for a given active compound is a profoundly important step from clinical, legal and regulatory perspectives, and PHARMORPHIX®’s expertise can ensure appropriate API performance for your selected dosage form.

Our Services (34)


ic

Electron Microscopy

Price on request

Scanning Electron Microscopy:

A range of instrumentation including benchtop and field emission SEM capabilities.  Resolutions down to <1nm along with elemental composition. Cryogenic capabilities.

Transmission Electron Microscopy:

Providing structural, chemical and  morphological information from micron to nano-scale regions of sample. Cryogenic capabilities.


ic

Micronization

Price on request

Proof of concept and small scale micronized material supply using a FPS Labomill-1 jet mill.


ic

Microscopy

Price on request
Request a quote for more information about this service.

ic

Hot Stage Microscopy

Price on request
Request a quote for more information about this service.

ic

Spray Drying

Price on request

Proof concept spray drying studies, including neat API, amorphous dispersions and co-crystal formation, using a Büchi Mini B-290.


ic

Polymorphism Screening

Price on request

The selection of a specific crystal form for a given API is a profoundly important step from clinical, legal and regulatory perspectives: for example, the dissolution rate and intrinsic solubility of different crystal forms is variable and can strongly influence bioavailability.


Pharmorphix’s expertise – we have conducted in excess of 400 polymorph screens, and worked on almost 40 compounds that are now commercial products – can ensure appropriate solid state performance for your selected dosage form.  


ic

Quantification of Amorphous Content

Price on request

A range of techniques, such as XRPD, DSC, Raman spectroscopy, Solid State NMR and GVS, available to quantify amorphous content in both drug substance and drug product samples.


ic

Drug Preformulation

Price on request
  • HPLC Method transfer and development – purity/assay analysis
  • Chemical stability analysis (Forced degradation studies/ stability)
  • Traditional shake-flask Thermodynamic and Kinetic solubility
  • Water determination by Karl Fischer
  • Confirmation of stoichiometry by Ion Chromatography
  • pKa/LogP
  • GI Tract Dissolution
  • Single sector and Multi-sector Dissolution
  • Solubility & pH profiling using the titration method
  • Surfactant and Excipient screening
  • Pre-formulation development (preparation for IND application)
  • Candidate selection and performance comparison (Co-crystals/Salts/Polymorphs)


ic

Solubility and Dissolution Testing

Price on request

Drug substance and drug product testing in buffered solutions and simulated fluids.

Sirius inForm and Omicron Research Ltd Distek Instrumentation.


ic

X-ray Photoelectron Spectrometry

Price on request

Powerful surface analytical method, suitable for any non-volatile material, allowing quantitative chemical analysis through studying all elements, except hydrogen, simultaneously.  Suitable applications include:

  • Confirmation of salt vs. cocrystal for pharmaceuticals to satisfy FDA guidance, typically in conjunction with other complimentary techniques.
  • Detection of catalyst poisons.


ic

SSNMR

Solid State Nuclear Magnet Resonance Spectroscopy
Price on request

Bruker Avance Neo 600 MHz spectrometer and Bruker Avance III 400 MHz spectrometers. Selected pharmaceutical applications include:

  • Quantification of crystalline form in drug substance and drug product samples.
  • Quantification of amorphous in drug substance and drug product samples.
  • Confirmation of the presence of both the API and coformer in the unit cell comply with FDA and EMA cocrystal guidance.
  • Confirmation of salt vs. cocrystal to comply with FDA cocrystal guidance through comparison of calculated and experimental shifts, original and geometry optimised structures based on single crystal data.


ic

Raman Mapping

Price on request

Raman mapping drug product samples for polymorphic content and amorphous quantification.


ic

Raman Spectroscopy

Price on request

Raman analysis of drug substance and drug product samples for polymorphic content and amorphous quantification.


ic

Dynamic Vapor Sorption

Price on request

Hygroscopicity measurement at RT to 50 degC.

Five DVS Intrinsic instruments by Surface Measurement Systems and Two Hiden IGASorp instruments.

Hiden instrumentation can also be used with organic solvents.


ic

Diastereomeric Salt Formation

Price on request

Classical resolution by diastereomeric salt formation:

  • Hit rate of greater than 70 % with regards to successful resolution. 
  • Developed resolution processes that are used in the production of commercial APIs.

Resolution by cocrystallisation.

Resolution by kinetic entrainment. 

Construction of phase diagrams to ensure robust process development.


ic

Salt Screening

Price on request

Poor oral bioavailability is increasingly an issue in the drug discovery process. Dosage form performance is one of the possible contributing factors to poor oral bioavailability. It is possible, therefore, to increase the dissolution rate and oral bioavailability of the API by modifying the physico-chemical properties of the API. When ionisable centres are present in the molecule, the preparation of an appropriate salt form which displays the right balance of solid state and physico-chemical properties is one of the most common approaches to modify the properties of the API and to enable the development of the corresponding API.

Pharmorphix has conducted in excess of 380 salt screening studies and our expertise can identify the most suitable salt for your selected dosage form, as well as generating additional intellectual property surrounding the solid state landscape of your molecule.


ic

Co-Crystallization

Price on request

Pharmorphix has been undertaking cocrystal screening studies since 2004 , Including over 50 screens since 2016. We have developed cocrystals to improve a range of properties including:

  • Dissolution rate and bioavailability.
  • Solubility in formulation media.
  • Skin irritation.
  • Melting point.

Pharmorphix has developed cocrystals on a number of marketed drugs, including in the following indications:

  • Moderate to severe Alzheimer’s.
  • Muscle relaxant .
  • Antiemetic .
  • BTK inhibitor .
  • Phosphodiesterase inhibitor .


In addition, Pharmorphix has experience generating the regulatory data required by both the FDA and EMA to confirm cocrystal formation, and subsequent in-vitro dissociation, and the location of the proton along the salt / cocrystal continuum.


ic

Crystal Structure Determination

Price on request

Structure collection and determination, including absolute stereochemistry confirmation, for small molecules.  Generation of comprehensive SCXRD reports, along with structure files (CIF, hkl, etc.), including ORTEP figures stereochemistry validation which can be used directly for regulatory and IP applications.


The SCXRD lab at JM Cambridge contains two fully automated and highly integrated Rigaku Oxford Diffraction dual source (Cu/Mo radiation) X-ray single crystal diffractometers: 

  • Rigaku XtaLAB Synergy-S diffractometer, equipped with a state-of the-art HyPix6000-HE Hybrid Photon Counting (HPC) detector, with fast read out times, a low background and high dynamic range. This instrument is also equipped with an Oxford Cryosystems Cobra 800 liquid nitrogen cooling device.
  • Oxford Diffration SuperNova X-ray Single Crystal Diffractometer is equipped with an Atlas CCD (Charge-Coupled Device) detector (active area of 135 mm) and an Oxford Cryosystems Cobra 700 liquid-nitrogen cooling device.


Data collections can be performed at specific temperatures, anywhere from 80 K to 400 K, and variable temperature SCXRD studies can be performed within this temperature range.


Availability of both Mo and Cu radiation allows for a much wider range of sample types to be explored by X-ray diffraction. Highly absorbing materials containing heavy elements can be evaluated using Mo radiation.  By contrast, Cu radiation is applicable for smaller, weaker diffracting organic samples and confirmation of absolute stereochemistry for samples containing only light atoms (C,H,N,O).


ic

Thermogravimetric Analysis (TGA)

Thermogravimetric Analysis
Price on request

TA Instruments Discovery TGA  and TA Instruments Q500 instrumentation.

Typical sample requirements ca. 10 mg.


ic

Differential Scanning Calorimetry (DSC)

Price on request

TA Instruments Discovery DSC and TA Instruments Q2000 instrumentation for DSC analyses, including modulated DSC.

Typical sample requirements ca. 5 mg.


ic

Rietveld Refinement

Price on request

PANalytical Empyrean and Bruker D8 Advance instruments.

Including crystal structure determination from powder data.


ic

X-ray Diffraction (XRD) Data Collection

Price on request

Structure collection and determination, including absolute stereochemistry confirmation, for small molecules. Generation of comprehensive SCXRD reports, along with structure files (CIF, hkl, etc.), including ORTEP figures stereochemistry validation which can be used directly for regulatory and IP applications.

The SCXRD lab at JM Cambridge contains two fully automated and highly integrated Rigaku Oxford Diffraction dual source (Cu/Mo radiation) X-ray single crystal diffractometers: 

  • Rigaku XtaLAB Synergy-S diffractometer, equipped with a state-of the-art HyPix6000-HE Hybrid Photon Counting (HPC) detector, with fast read out times, a low background and high dynamic range. This instrument is also equipped with an Oxford Cryosystems Cobra 800 liquid nitrogen cooling device.
  • Oxford Diffration SuperNova X-ray Single Crystal Diffractometer is equipped with an Atlas CCD (Charge-Coupled Device) detector (active area of 135 mm) and an Oxford Cryosystems Cobra 700 liquid-nitrogen cooling device.

Data collections can be performed at specific temperatures, anywhere from 80 K to 400 K, and variable temperature SCXRD studies can be performed within this temperature range.

Availability of both Mo and Cu radiation allows for a much wider range of sample types to be explored by X-ray diffraction. Highly absorbing materials containing heavy elements can be evaluated using Mo radiation. By contrast, Cu radiation is applicable for smaller, weaker diffracting organic samples and confirmation of absolute stereochemistry for samples containing only light atoms (C,H,N,O).


ic

X-Ray Diffraction (XRD)

Price on request

Structure collection and determination, including absolute stereochemistry confirmation, for small molecules. Generation of comprehensive SCXRD reports, along with structure files (CIF, hkl, etc.), including ORTEP figures stereochemistry validation which can be used directly for regulatory and IP applications.


Crystal growth projects to generate single crystals suitable for structure determination.

The SCXRD lab at JM Cambridge contains two fully automated and highly integrated Rigaku Oxford Diffraction dual source (Cu/Mo radiation) X-ray single crystal diffractometers: 

  • Rigaku XtaLAB Synergy-S diffractometer, equipped with a state-of the-art HyPix6000-HE Hybrid Photon Counting (HPC) detector, with fast read out times, a low background and high dynamic range. This instrument is also equipped with an Oxford Cryosystems Cobra 800 liquid nitrogen cooling device.  
  • Oxford Diffration SuperNova X-ray Single Crystal Diffractometer is equipped with an Atlas CCD (Charge-Coupled Device) detector (active area of 135 mm) and an Oxford Cryosystems Cobra 700 liquid-nitrogen cooling device.

Data collections can be performed at specific temperatures, anywhere from 80 K to 400 K, and variable temperature SCXRD studies can be performed within this temperature range.  

Availability of both Mo and Cu radiation allows for a much wider range of sample types to be explored by X-ray diffraction. Highly absorbing materials containing heavy elements can be evaluated using Mo radiation. By contrast, Cu radiation is applicable for smaller, weaker diffracting organic samples and confirmation of absolute stereochemistry for samples containing only light atoms (C,H,N,O).


ic

X-Ray Powder Diffraction

Price on request

Variable temperature, variable humidity and vacuum XRPD capabilities.  

XRPD analysis of drug substance and drug product samples, including computed tomography.

Polymorphic content and amorphous quantification.

Crystal structure determination from powder data.

PANalytical Empyrean, Bruker D8 Advance and Bruker C2 GADDS instruments.


ic

Process Consulting

Price on request
Request a quote for more information about this service.

ic

Analytical Chemistry Services

Price on request
Request a quote for more information about this service.

ic

Solid-State Chemistry

Price on request

Johnson Matthey has leading capabilities in developing optimal polymorphs, salt forms, crystal morphology and controlled particles through our PHARMORPHIX® solid form sciences. We offer one of the broadest and most reliable services to ensure effective identification, development and manufacture of your drug candidates and commercial products.

Pharmorphix has completed in excess of 2,000 customer projects in this area and our expertise and innovation has led to almost 40 APIs making the transition to market. Indeed, since 2014 over 20 % of the small molecule drugs approved by the FDA have previously been investigated at Pharmorphix. Our experience in solid state chemistry will ensure appropriate API performance for your selected dosage form.


ic

Chromatography

Price on request
Request a quote for more information about this service.

ic

Synthetic Building Blocks and Intermediates

Price on request
Request a quote for more information about this service.

ic

Biocatalyst Development

Price on request
Request a quote for more information about this service.

ic

Chemical Engineering and Processing

Price on request
Request a quote for more information about this service.

ic

Chemistry and Materials

Price on request
Request a quote for more information about this service.

ic

Synthetic Chemistry

Price on request
Request a quote for more information about this service.

ic

X-ray Crystallography

Price on request

Structure collection and determination, including absolute stereochemistry confirmation, for small molecules. Generation of comprehensive SCXRD reports, along with structure files (CIF, hkl, etc.), including ORTEP figures stereochemistry validation which can be used directly for regulatory and IP applications.

The SCXRD lab at JM Cambridge contains two fully automated and highly integrated Rigaku Oxford Diffraction dual source (Cu/Mo radiation) X-ray single crystal diffractometers:

  • Rigaku XtaLAB Synergy-S diffractometer, equipped with a state-of the-art HyPix6000-HE Hybrid Photon Counting (HPC) detector, with fast read out times, a low background and high dynamic range. This instrument is also equipped with an Oxford Cryosystems Cobra 800 liquid nitrogen cooling device. 
  • Oxford Diffration SuperNova X-ray Single Crystal Diffractometer is equipped with an Atlas CCD (Charge-Coupled Device) detector (active area of 135 mm) and an Oxford Cryosystems Cobra 700 liquid-nitrogen cooling device.


Data collections can be performed at specific temperatures, anywhere from 80 K to 400 K, and variable temperature SCXRD studies can be performed within this temperature range.

Availability of both Mo and Cu radiation allows for a much wider range of sample types to be explored by X-ray diffraction. Highly absorbing materials containing heavy elements can be evaluated using Mo radiation. By contrast, Cu radiation is applicable for smaller, weaker diffracting organic samples and confirmation of absolute stereochemistry for samples containing only light atoms (C,H,N,O).


Not finding what you're looking for?

Get info on this provider's capabilities without requesting a quote.
CW

Chris Worrall

Technical Sales Manager

FileType/PDF Created with Sketch. JM API and Controlled Substance Product Guide US 2020.pdf

Click to Download

FileType/PDF Created with Sketch. JM Catalysts Product Guide A4.pdf

Click to Download

FileType/PDF Created with Sketch. JM-Pharmaceutical Products and Services Brochure.pdf

Click to Download

FileType/PDF Created with Sketch. JM-Solid State Services Flyer.pdf

Click to Download

Johnson Matthey has not received any reviews.

Johnson Matthey has not received any endorsements.